Pharmafile Logo
Pharmafocus logo
Advanced Search

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

October 21, 2024
Research and Development CHMP, EMA, EU, Internal Medicine, gene

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …

News

Eli Lilly appoints new chief AI officer

October 17, 2024
AI and ML, Corporate, Eli Lilly

Eli Lilly has announced the appointment of Thomas J Fuchs as its first chief artificial intelligence (AI) officer. Fuchs’ appointment …

Appointment

FlyPharma Europe, Vienna – 23-24 October 2024 conference

October 14, 2024
Conference, Corporate, flypharma, pharmaceutical

Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return to Office Park 4, Vienna …

News
Press release

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024
Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …

News
Press release
handshake

Strategic alliance announced between Recipharm and Exela

October 1, 2024
Research and Development Corporate, Exela, Recipharm, US

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …

News

Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone

October 1, 2024
Research and Development Cardiology, Duchenne Muscular Dystrophy, Immunology, Santhera Pharmaceuticals, clinical studies

Santhera Pharma has announced the results of its LIONHEART study, which evaluated vamorolone – a corticosteroid – and confirmed its …

News

Prilenia appoints new management staff to advance company’s development and commercialisation plans

September 30, 2024
Corporate, prilenia

Prilenia, a clinical stage biotech focusing on neurodegenerative and neurodevelopmental disorders, has announced the appointment of two new senior staff …

Appointment

Vertex Highlights First Oral Presentation of Phase 3 Clinical Dataof the Vanzacaftor Triple Combination and New Data on Long-Term Impact of TRIKAFTA at the North American CysticFibrosis Conference

September 30, 2024
Vertex Pharma

Phase 3 data on investigational vanzacaftor triple combination demonstrates noninferiorityto TRIKAFTA® in ppFEV1 and further improvement of CFTR functionas measured …

News
Press release

Eli Lilly announces two senior hires in Public Affairs and Communications team

September 27, 2024
Corporate, Eli Lilly

Pharmaceutical company Eli Lilly has announced the appointment of two senior positions in its Public Affairs and Communications team. James …

Appointment

Laurence Reid and Brad Crutchfield appointed to Broken Strings’ board of directors

September 25, 2024
Broken String Biosciences, Corporate

Cambridge, UK-based genomics company Broken String Biosciences has announced the appointment of Laurence Reid PhD as chairman, and Brad Crutchfield …

Appointment

Third application for Orion’s prostate cancer drug submitted by partner Bayer

September 23, 2024
Bayer, Cancer, Oncology, orion, prostate cancer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application of its prostate cancer drug, …

News

Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin

September 19, 2024
Business Services, Research and Development AI, Corporate, LabTwin, laboratory

The two Berlin-based companies labforward and LabTwin, a subsidiary of the life science group Sartorius, are merging in order to …

News
Press release

Steriline’s founder “passes torch” to children with CEO and CSO appointments

September 19, 2024
Corporate, Steriline

Aseptic packaging company Steriline’s founder Gerardo Fumagalli has “passed the torch” to his children Illaria Fumagalli and Federico Fumagalli, who …

Appointment

Butterfly Network Expands its Next-Generation Butterfly iQ3™ to Europe

September 11, 2024
Butterfly Network, medical imaging

Butterfly iQ3 is built on the next-generation Ultrasound-on-Chip™ technology featuring unparalleled image quality, new 3D imaging capabilities, and a smaller, …

News
Press release

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

September 9, 2024
Research and Development Rare Diseases

9 September 2024, –London, UK –Applications for the independently assessed, expert-led Research Grant Initiative, Find For Rare, are open from …

News
Press release

Amferia closes €1,2 million investment to combat resistant bacterial infections

September 3, 2024
Research and Development Amferia, Chalmers Ventures, Dressings, hosiery & appliances, Hospital Management, Immunology, antimicrobial, investment, peptides

Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …

News
Press release
bowel_cancer_screening

The National Institute for Health and Care Excellence announce technology appraisal guidance recommending risankizumab for adult patients with moderate to severe ulcerative colitis

August 29, 2024
Research and Development AbbVie, Crohns, Gastrointestinal tract, Immunology, NICE, approval, ulcerative colitis

The National Institute for Health and Care Excellence (NICE) have recommended adult patients in England or Wales with moderately or …

News

Leadership Appointments at RQM+

August 28, 2024
Research and Development AI and ML, Corporate, RQM+, appointment

Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager On August 27, MedTech service provider RQM+ announced …

Appointment
lungs

European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients

August 27, 2024
Research and Development J&J, Oncology, chemotherapy, non-small cell lung cancer

Today, Janssen-Cilag International, part of Johnson & Johnson (J&J) has announced that the European Comission (EC) has approved a combined …

News

New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain

August 16, 2024
GEJ cancers, Gastrointestinal tract, MHRA, Oncology, gastric cancer

Claudin18.2 is an innovative drug-target which is not currently used for any other authorised treatment. There is a large unmet …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025